Index by author
November 01, 2008; Volume 36,Issue 11
Abadie, Catherine
- You have accessMetabolism of Phenylahistin Enantiomers by Cytochromes P450: A Possible Explanation for Their Different CytotoxicityLionel Perrin, Caroline Aninat, Véronique Hamon, Yoshio Hayashi, Catherine Abadie, Bruno Heyd, François André and Marcel DelaforgeDrug Metabolism and Disposition November 2008, 36 (11) 2381-2392; DOI: https://doi.org/10.1124/dmd.107.019919
Aboutabl, Mona E.
- You have accessModulation of Cytochrome P450 Gene Expression and Arachidonic Acid Metabolism during Isoproterenol-Induced Cardiac Hypertrophy in RatsBeshay N. M. Zordoky, Mona E. Aboutabl and Ayman O. S. El-KadiDrug Metabolism and Disposition November 2008, 36 (11) 2277-2286; DOI: https://doi.org/10.1124/dmd.108.023077
Allen, Ann
- You have accessMetabolism and Disposition of Fluticasone Furoate, an Enhanced-Affinity Glucocorticoid, in HumansStephen C. Hughes, Peter C. Shardlow, Frank J. Hollis, Rebecca J. Scott, Dimple S. Motivaras, Ann Allen and Victoria M. RousellDrug Metabolism and Disposition November 2008, 36 (11) 2337-2344; DOI: https://doi.org/10.1124/dmd.108.022137
Alworth, Bill
- You have accessDifferential Inhibition of Cytochromes P450 3A4 and 3A5 by the Newly Synthesized Coumarin Derivatives 7-Coumarin Propargyl Ether and 7-(4-Trifluoromethyl)coumarin Propargyl EtherChitra Sridar, Ute M. Kent, Kate Noon, Alecia McCall, Bill Alworth, Maryam Foroozesh and Paul F. HollenbergDrug Metabolism and Disposition November 2008, 36 (11) 2234-2243; DOI: https://doi.org/10.1124/dmd.108.021493
Andre, François
- You have accessMetabolism of Phenylahistin Enantiomers by Cytochromes P450: A Possible Explanation for Their Different CytotoxicityLionel Perrin, Caroline Aninat, Véronique Hamon, Yoshio Hayashi, Catherine Abadie, Bruno Heyd, François André and Marcel DelaforgeDrug Metabolism and Disposition November 2008, 36 (11) 2381-2392; DOI: https://doi.org/10.1124/dmd.107.019919
Aninat, Caroline
- You have accessMetabolism of Phenylahistin Enantiomers by Cytochromes P450: A Possible Explanation for Their Different CytotoxicityLionel Perrin, Caroline Aninat, Véronique Hamon, Yoshio Hayashi, Catherine Abadie, Bruno Heyd, François André and Marcel DelaforgeDrug Metabolism and Disposition November 2008, 36 (11) 2381-2392; DOI: https://doi.org/10.1124/dmd.107.019919
Aristei, Yasmin
- You have accessThe Molecular Basis of CYP2D6-Mediated N-Dealkylation: Balance between Metabolic Clearance Routes and Enzyme InhibitionBritta Bonn, Collen M. Masimirembwa, Yasmin Aristei and Ismael ZamoraDrug Metabolism and Disposition November 2008, 36 (11) 2199-2210; DOI: https://doi.org/10.1124/dmd.108.022376
Atkins, William
- You have accessPrincipal Component Analysis of CYP2C9 and CYP3A4 Probe Substrate/Inhibitor PanelsAbhinav Nath and William AtkinsDrug Metabolism and Disposition November 2008, 36 (11) 2151-2155; DOI: https://doi.org/10.1124/dmd.108.022061
Bonn, Britta
- You have accessThe Molecular Basis of CYP2D6-Mediated N-Dealkylation: Balance between Metabolic Clearance Routes and Enzyme InhibitionBritta Bonn, Collen M. Masimirembwa, Yasmin Aristei and Ismael ZamoraDrug Metabolism and Disposition November 2008, 36 (11) 2199-2210; DOI: https://doi.org/10.1124/dmd.108.022376
Bratton, Stacie M.
- You have accessIdentification of Hydroxywarfarin Binding Site in Human UDP Glucuronosyltransferase 1A10: Phenylalanine90 Is Crucial for the Glucuronidation of 6- and 7-Hydroxywarfarin but Not 8-HydroxywarfarinGrover P. Miller, Cheryl F. Lichti, Agnieszka K. Zielinska, Anna Mazur, Stacie M. Bratton, Anna Gallus-Zawada, Moshe Finel, Jeffery H. Moran and Anna Radominska-PandyaDrug Metabolism and Disposition November 2008, 36 (11) 2211-2218; DOI: https://doi.org/10.1124/dmd.108.022863
In this issue
Advertisement